234
Views
10
CrossRef citations to date
0
Altmetric
Review

Advances in small molecule therapy for treating metastatic thyroid cancer

, &
Pages 1049-1060 | Received 26 Mar 2017, Accepted 07 Jun 2017, Published online: 03 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Carla Júnia Santos, Daniel Crístian Ferreira Soares, Carolina de Aguiar Ferreira, André Luís Branco de Barros, Armando da Silva Cunha Junior & Francisco Moura Filho. (2018) Antiangiogenic evaluation of ZnWO4 nanoparticles synthesised through microwave-assisted hydrothermal method. Journal of Drug Targeting 26:9, pages 806-817.
Read now

Articles from other publishers (9)

Jan Stępniak, Joanna Krawczyk-Lipiec, Andrzej Lewiński & Małgorzata Karbownik-Lewińska. (2022) Sorafenib versus Lenvatinib Causes Stronger Oxidative Damage to Membrane Lipids in Noncancerous Tissues of the Thyroid, Liver, and Kidney: Effective Protection by Melatonin and Indole-3-Propionic Acid. Biomedicines 10:11, pages 2890.
Crossref
Siqin Zhang, Shaoyong Chen, Yuchen Wang, Yuxiang Zhan, Jiarui Li, Xiaolin Nong & Biyun Gao. (2021) Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma. Frontiers in Genetics 12.
Crossref
Chiara Romano, Federica Martorana, Maria Stella Pennisi, Stefania Stella, Michele Massimino, Elena Tirrò, Silvia Rita Vitale, Sandra Di Gregorio, Adriana Puma, Cristina Tomarchio & Livia Manzella. (2021) Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer. International Journal of Molecular Sciences 22:14, pages 7707.
Crossref
K.A. GARIPOV, Z.A. AFANASIEVA & A.D. GAFIULLINA. (2020) APOPTOSIS ROLE IN FORMING RADIOIODINE RESISTANCE IN DIFFERENTIATED THYROID CANCER. AVICENNA BULLETIN, pages 301-310.
Crossref
Elena Tirrò, Federica Martorana, Chiara Romano, Silvia Rita Vitale, Gianmarco Motta, Sandra Di Gregorio, Michele Massimino, Maria Stella Pennisi, Stefania Stella, Adriana Puma, Fiorenza Gianì, Marco Russo, Livia Manzella & Paolo Vigneri. (2019) Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice. Genes 10:9, pages 709.
Crossref
Evgeniya A. Sokolova, Vladimir A. Vodeneev, Sergey M. Deyev & Irina V. Balalaeva. (2019) 3D in vitro models of tumors expressing EGFR family receptors: a potent tool for studying receptor biology and targeted drug development. Drug Discovery Today 24:1, pages 99-111.
Crossref
Feng Liu, Jin Zhang, Long Qin, Ziyao Yang, Jianxia Xiong, Yanyan Zhang, Ruihuan Li, Shujing Li, Huifang Wang, Bo Yu, Wenjun Zhao, Weiran Wang, Zhensu Li & Jing Liu. (2018) Circular RNA EIF6 (Hsa_circ_0060060) sponges miR-144-3p to promote the cisplatin-resistance of human thyroid carcinoma cells by autophagy regulation. Aging 10:12, pages 3806-3820.
Crossref
Robert RoskoskiJr.Jr. & Abdollah Sadeghi-Nejad. (2018) Role of RET protein-tyrosine kinase inhibitors in the treatment RET-driven thyroid and lung cancers. Pharmacological Research 128, pages 1-17.
Crossref
Dagmara Rusinek, Ewa Chmielik, Jolanta Krajewska, Michal Jarzab, Malgorzata Oczko-Wojciechowska, Agnieszka Czarniecka & Barbara Jarzab. (2017) Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?. International Journal of Molecular Sciences 18:8, pages 1817.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.